Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $7.1050 (-3.46%) ($7.1050 - $7.1050) on Tue. Jul. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.68% (three month average) | RSI | 55 | Latest Price | $7.1050(-3.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.7% a day on average for past five trading days. | Weekly Trend | IOVA declines -0.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) GLD(56%) XBI(26%) IGOV(25%) SLV(22%) GDX(21%) | Factors Impacting IOVA price | IOVA will decline at least -2.84% in a week (0% probabilities). UUP(-31%) XLU(-26%) XLP(-21%) TBT(-21%) XME(-20%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.84% (StdDev 5.68%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.56 | 5 Day Moving Average | $7.52(-5.52%) | 10 Day Moving Average | $7.7(-7.73%) | 20 Day Moving Average | $7.56(-6.02%) | To recent high | -22% | To recent low | 32.4% | Market Cap | $1.04b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |